Jason C. Jones - Dec 9, 2025 Form 4 Insider Report for EKSO BIONICS HOLDINGS, INC. (EKSO)

Signature
/s/ Jerome Wong
Stock symbol
EKSO
Transactions as of
Dec 9, 2025
Transactions value $
-$1,269
Form type
4
Date filed
12/10/2025, 04:05 PM
Previous filing
Nov 12, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Jones Jason C Chief Operating Officer 101 GLACIER POINT, SUITE A, SAN RAFAEL /s/ Jerome Wong 2025-12-10 0001775619

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EKSO Common Stock Sale -$1.27K -270 -0.99% $4.70 26.9K Dec 9, 2025 Direct F1, F2, F3
holding EKSO Common Stock 3.14K Dec 9, 2025 By 401(k) F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the Reporting Person on December 9, 2025 to cover tax withholding obligations incurred upon the vesting and settlement of restricted stock awards originally reported by the Reporting Person in Form 4's filed with the Commission on June 15, 2023 and December 6, 2022.
F2 These shares were sold in a single transaction at a price of $4.7048 per share.
F3 On June 2, 2025, the Issuer effected a 1-for-15 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.